- ACOG Congratulates Dr. Tedros Adhanom Ghebreyesus as the new Director-General of WHO
- Ob-Gyns Play Key Role in Diagnosing and Treating a Common Condition in Female Athletes
Ob-gyns have an important role to play in the health of female athletes, according to the latest guidance released from The American College of Obstetricians and Gynecologists (ACOG). Menstruation is a key vital sign, as well as an important factor in recognizing a medical condition observed in physically active girls and women known as the female athlete triad.
- CDC Convenes Webinar on Falsely Low Blood Lead Test Results
- FDA Warns of Inaccurate Lead Test Results, CDC Recommends Re-Test for Certain Pregnant or Lactating Women
The U.S. Food and Drug Administration (FDA) has issued a safety communication warning about the use of Magellan Diagnostics’ LeadCare® analyzers (LeadCare, LeadCare II, LeadCare Ultra and LeadCare Plus) with venous blood samples because they might result in falsely low test results. As a result, the Centers for Disease Control and Prevention (CDC) is now recommending that health care providers re-test currently pregnant or lactating women who had a venous blood lead test performed using a Magellan Diagnostics’ LeadCare® analyzer.
- Junior Fellow 2017 Elections: Call for Nominations
All Districts are seeking interested, qualified Junior Fellows for District Vice Chair and District Secretary-Treasurer for the 2017-2018 term. Please note: In order to qualify as a candidate, one must plan to remain in the District during their 3-year term of office.
- Haywood L. Brown, M.D., Becomes 68th President of The American College of Obstetricians and Gynecologists
Today, Haywood L. Brown, M.D., of Durham, North Carolina, became the 68th president of The American College of Obstetricians and Gynecologists (ACOG), based in Washington, D.C. In assuming this role, Brown also became the president of The American Congress of Obstetricians and Gynecologists.
- ACOG Elects New Officers
Today, The American Congress of Obstetricians and Gynecologists (ACOG) announced the election of Lisa M. Hollier, M.D., M.P.H., of Houston, Texas as president-elect; Wanda K. Nicholson, M.D., M.P.H., M.B.A., of Chapel Hill, North Carolina as Fellow-at-Large; and Hartaj K. Powell, M.D., M.P.H., of Reston, Virginia as Young Physician-at-Large. They assumed their respective offices on May 8, 2017.
- Largest Gathering of Women's Health Providers Meet in San Diego for ACOG's 2017 Annual Meeting
Nearly 5,000 attendees are expected to participate in the 2017 Annual Clinical and Scientific Meeting held by The American College of Obstetricians and Gynecologists (ACOG), marking the 65th meeting for the association which ends on May 9. This year’s theme, “Next Generation of Health Care,” will focus on how to prepare ob-gyns to meet the challenges ahead.
- Research Awards Announced for ACOG 2017 Annual Meeting
The American College of Obstetricians and Gynecologists (ACOG) is pleased to announce the 2017 Annual Clinical and Scientific Meeting research award winners, who were selected from among more than 700 outstanding original research papers and posters to be presented at this year’s event.
- Statement by ACOG President Thomas Gellhaus, MD on Elimination of Title X Funding
It’s hard to imagine that Congress is actually considering passing legislation that would eliminate funding for family planning services when we’re looking directly at the Zika virus crisis. The American Congress of Obstetricians and Gynecologists (ACOG), representing more than 57,000 physicians and partners in women’s health, urges the House to change course on its FY 2017 Labor-HHS-Education appropriations bill, and restore funding for Title X family planning services. As others have said, we may not yet know how to cure Zika, but we know how to prevent pregnancies, and that’s through contraception. Contraception is, in fact, our best weapon to keep moms and babies safe. This bill completely misses the mark.
- ACOG Opposes Executive Order Limiting Access to Comprehensive Health Care Under Religious Freedom Exemption
“Contraceptives are essential care for women and must not be treated differently than other, equally important parts of comprehensive care, including vaccination, antibiotics or annual physical examinations."
- ACOG Condemns House Passage of the AHCA
"The facts are that cutting $880 billion out of the Medicaid program, eliminating Medicaid expansion, denying qualified providers the ability to offer Medicaid-covered primary and preventive care, allowing states to opt out of covering essential benefits including maternity care, and weakening protections for people with pre-existing conditions all lead to only one result: sicker patients and higher health care costs."
- America’s Frontline Physicians Urge U.S. Senate to Find a New Way Forward with Health Care
Regrettably, the AHCA, as amended and passed by the House, violates our principles, dramatically increasing costs for older individuals, resulting in millions of people losing their health care coverage, and returning to a system that allows insurers to discriminate against people with pre-existing conditions. We also oppose the AHCA’s Medicaid cuts, including: capping and cutting the federal government’s contribution to Medicaid, sunsetting federal funding for Medicaid expansion, and eliminating Medicaid coverage of essential benefits.
- Leading Women’s Health Organizations Recommend Strategies to Enable Adequate Pain Control and Continued Breastfeeding
The American College of Obstetricians and Gynecologists (ACOG), the Society for Maternal-Fetal Medicine (SMFM), and The Academy of Breastfeeding Medicine (ABM) released the following statement regarding the U.S. Food and Drug Administration’s (FDA) new guidance on codeine and tramadol in breastfeeding mothers:
- Practice Advisory on Codeine and Tramadol for Breastfeeding Women
On April 20, 2017, the U.S. Food and Drug Administration (FDA) issued a Drug Safety Communication and announced revisions to the labels of all prescription medicines containing codeine and tramadol. Among the label changes is a strengthened warning that breastfeeding is not recommended while using medicines containing codeine or tramadol, because of the potential for serious adverse effects in the infant due to opioid overdose (1).